From the anterior segment to the posterior segment, nobody covers the eye like Ora.

In the world of dry eye, it’s not about finding the most subjects.

It’s about finding the right subjects.

500,000 CACs and 19 FDA approvals later, the Allergy breakthroughs keep coming.

Searching for the best indication for your retina candidate?

Our Retina Group can sharpen your focus.

Ora is the world’s leading ophthalmic CRO

We have more than 30 years of highly focused ophthalmic expertise, during which time we have helped our clients obtain 34 product approvals. We provide consulting and development services to the ophthalmic drug and device industry, including biotech start-ups, global pharmaceutical companies and investors.

We have specific expertise in ophthalmic clinical-regulatory strategy and clinical trial execution, including phase I-IV clinical development, statistics and data management, pre-clinical strategy and studies, CMC management, marketing support and due-diligence. We work across all ophthalmic indications and conduct research in North America, Europe, Asia and South America.